Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZL-85FA in advanced solid tumors
NCT07339748Phase 2Not yet recruiting
- Sponsor
- Zenitar
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZL-85FA in solid tumor (advanced stage), breast cancer, ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Zenitar. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ZL-85FA
03
Conditions
solid tumor (advanced stage)breast cancerovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT07339748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07339748.